
Sign up to save your podcasts
Or


Netflix rises on strong 1st quarter numbers and a well-executed price increase. Valeant Pharmaceuticals makes a $45 billion bid for Allergan. Plus, we analyze the latest results from McDonald’s and the new “Pay To Quit” program at Amazon.
By The Motley Fool4.7
16041,604 ratings
Netflix rises on strong 1st quarter numbers and a well-executed price increase. Valeant Pharmaceuticals makes a $45 billion bid for Allergan. Plus, we analyze the latest results from McDonald’s and the new “Pay To Quit” program at Amazon.

3,230 Listeners

1,500 Listeners

806 Listeners

942 Listeners

531 Listeners

1,186 Listeners

2,189 Listeners

825 Listeners

1,431 Listeners

1,047 Listeners

9,717 Listeners

194 Listeners

829 Listeners

84 Listeners

589 Listeners

1,034 Listeners

50 Listeners